| Type of Capital Measure |
Date (MM/DD/JJ) |
Gross proceeds (Mio. €) |
Issue price (€) |
Total number of shares after issuance |
Number of shares issued |
| Capital Increase against Cash (SEDA2) |
30/06/2010 |
1,5 |
2.55 |
37,082,758 |
588,235 |
| Capital Increase against Cash (SEDA2) |
04/05/2010 |
1 |
2.76 |
36,494,523 |
362,318 |
| Capital Increase against Cash (SEDA2) |
24/03/2010 |
2 |
3.48 |
36,132,205 |
574,712 |
| Capital Increase against Cash (SEDA2) |
11/12/2009 |
2 |
3.52 |
35,557,493 |
568,181 |
| Capital Increase against Cash (SEDA2) |
18/11/2009 |
2 |
3.94 |
34,989,312 |
507,614 |
| Capital Increase against Cash (SEDA2) |
02/11/2009 |
1 |
4.46 |
34,481,698 |
224,215 |
| Capital Increase against Cash (SEDA2) |
13/10/2009 |
1 |
4.87 |
34,257,483 |
205,338 |
| Capital Increase against Cash (SEDA2) |
03/06/2009 |
0.1 |
4.24 |
34,052,145,00 |
23,584 |
| Capital Increase against Cash |
10/09/2007 |
15,6 |
5.05 |
33,927,121 |
3,084,282 |
| Capital Increase against Cash |
02/14/2007 |
12.6 |
6.10 |
30,842,839 |
2,062,040 |
| Acquisition of Avidex Ltd. |
09/27/2006 |
50.1 |
6.00 |
28,651,070 |
8,157,787 |
| Capital Increase against Cash |
03/02/2006 |
15.7 |
8.45 |
20,620,452 |
1,852,260 |
| Conversion of all outstanding bonds issued on March 24, 2004 |
12/16/2005 |
- |
7.48 |
18,722,666 |
199,982 |
| Capital Increase against Cash |
11/15/2004 |
21.6 |
7.00 |
18,522,684 |
3,087,114 |
| Acquisition of the Assets of Munich Biotech AG |
08/13/2004 |
11.3 |
5.76 |
15,435,170 |
1,960,938 |
| Issuance of Convertible Bonds at a price of 1 € each |
03/24/2004 |
1.5 |
1.00 |
13,474,032 |
- |
| Capital Increase against Cash |
03/24/2004 |
15.3
1.51) |
6.80
1.001) |
13,474,032 |
1,122,835
1.122.835
- |
| Acquisition of NeuroVir Therapeutics Inc., San Diego, USA |
01/12/2001 |
90.2 |
90.50 |
11,162,288 |
996,631 |
| Initial Public Offering / Capital Increase against Cash |
06/30/2000 |
125.4 |
42.00 |
10,100,000 |
2,985,354 |
1) Issuance of 1,500,000 convertible bonds at a price of 1 € each
2) SEDA - Standby Equity Distribution Agreement
|
